Concourse Financial Group Securities, Inc. Biovie Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$0.4 - $0.56 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.53 - $1.89 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.22 - $5.24 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$2.75 - $5.17 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$2.75 - $5.17 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$4.09 - $8.29 $0 - $0
Q1 2023 May 15, 2023	BUY	$4.89 - $10.53 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$3.86 - $42.0 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.38 - $25.6 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.44 - $5.04 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.74 - $5.65 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.41 - $6.99 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$6.69 - $16.93 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$10.57 - $21.61 $0 - $0
Q1 2021 May 13, 2021	BUY	$14.35 - $44.81 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$7.85 - $17.32 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$9.0 - $265.0 $0 - $0

Others Institutions Holding BIVI

# of Institutions

Shares Held

4.73M

Call Options Held

17.2K

Put Options Held

27K

Altium Capital Management LP New York, NY

1.98M
Shares

$5.49 Million
0.42% of portfolio
Sabby Management, LLC Upper Saddle River, NJ

733K
Shares

$2.03 Million
19.26% of portfolio
Vanguard Group Inc Valley Forge, PA

568K
Shares

$1.57 Million
0.0% of portfolio
Swisspartners Ltd. Vaduz, N2

294K
Shares

$815,338
2.92% of portfolio
Geode Capital Management, LLC Boston, MA

232K
Shares

$641,687
0.0% of portfolio

View Full List

About BIOVIE INC.

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

More about BIVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account